Lunesta News 4
Drug to shake up insomnia market
Sepracor says Lunesta will keep users asleep longer than rivals can.
Sepracor, of Marlborough, said the Drug Enforcement Agency on Monday will publish rules to let it begin selling its prescription drug Lunesta, and that more than 40,000 pharmacies have already placed orders.
For the complete article, click here
Information provided on this site is for educational purposes only. Lunesta is a registered trademark of Sepracor Inc. This site is not endorsed or affiliated with Sepracor Inc. in any way.
